Abstract
Nocturnal asthma is a significant clinical problem in asthmatics that can lead to sleep disruption, daytime fatigue and hypersomnolence. There is increased sleep latency, reduced sleep efficiency and reduction in slow wave sleep. Circadian changes in airway lumen are exaggerated in nocturnal asthma. Hormonal variations at night, increased airway hyperreactivity with inflammation, decreased lung volume and increased intrathoracic blood volume contribute to the pathophysiology. Nocturnal asthmatics demonstrate a reduction in glucocorticoid receptor binding affinity at night as well as an increase in the glucocorticoid receptor splice variant which reduces the efficacy of steroids. Both the number and physiologic function of beta-2 receptors are significantly decreased from 4 PM to 4 AM in asthmatics with nocturnal worsening compared to non-nocturnal asthmatics and normal controls. Chronotherapeutically administered steroids may have an additional role in control of nocturnal asthma. There is a high prevalence of OSA in patients with asthma. This appears to be bidirectional relationship. Females are affected with both concomitantly more often than males. OSA augments asthmatic inflammation at night. Treatment with CPAP improves asthma control without affecting lung functions or airway hyperreactivity.
Keywords: Asthma, sleep, obstructive sleep apnea, nocturnal asthma, obesity, chronobiology
Current Respiratory Medicine Reviews
Title: Sleep and Asthma
Volume: 5 Issue: 4
Author(s): Shahida Bashir and Shekhar A. Ghamande
Affiliation:
Keywords: Asthma, sleep, obstructive sleep apnea, nocturnal asthma, obesity, chronobiology
Abstract: Nocturnal asthma is a significant clinical problem in asthmatics that can lead to sleep disruption, daytime fatigue and hypersomnolence. There is increased sleep latency, reduced sleep efficiency and reduction in slow wave sleep. Circadian changes in airway lumen are exaggerated in nocturnal asthma. Hormonal variations at night, increased airway hyperreactivity with inflammation, decreased lung volume and increased intrathoracic blood volume contribute to the pathophysiology. Nocturnal asthmatics demonstrate a reduction in glucocorticoid receptor binding affinity at night as well as an increase in the glucocorticoid receptor splice variant which reduces the efficacy of steroids. Both the number and physiologic function of beta-2 receptors are significantly decreased from 4 PM to 4 AM in asthmatics with nocturnal worsening compared to non-nocturnal asthmatics and normal controls. Chronotherapeutically administered steroids may have an additional role in control of nocturnal asthma. There is a high prevalence of OSA in patients with asthma. This appears to be bidirectional relationship. Females are affected with both concomitantly more often than males. OSA augments asthmatic inflammation at night. Treatment with CPAP improves asthma control without affecting lung functions or airway hyperreactivity.
Export Options
About this article
Cite this article as:
Bashir Shahida and Ghamande A. Shekhar, Sleep and Asthma, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112456
DOI https://dx.doi.org/10.2174/157339809790112456 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Binding Interactions of Forskolin with Human Serum Albumin: Insights from In silico and Spectroscopic Studies
Current Chemical Biology Sulfation in Dog
Current Drug Metabolism Milestones in the Development of Chronic LPS-Induced Airway Disease
Current Respiratory Medicine Reviews Flavonoids as Potential Anti-Allergic Substances
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Silver Based Materials for Biomedical Applications
Current Organic Chemistry Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology Current Issues in Pharmaceutical Residues in Drinking Water
Current Analytical Chemistry Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry Genetic Signatures in the Treatment of Stroke
Current Pharmaceutical Design Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Natural Products as Anti-glycation Agents: Possible Therapeutic Potential for Diabetic Complications
Current Diabetes Reviews Searching the Staphylococcal Toxic Shock Syndrome Toxin -1 in Septic Children with negative Cultures: A Comparative Study in Tehran, Iran
Infectious Disorders - Drug Targets Treating COPD in Older and Oldest Old Patients
Current Pharmaceutical Design Sarcolemmal K<sub>ATP</sub> Channel Modulators and Cardiac Arrhythmias
Current Medicinal Chemistry Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
Mini-Reviews in Medicinal Chemistry Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design Common Issues Among Asthma, Epilepsy, and Schizophrenia: From Inflammation to Ca<sup>2+</sup>/cAMP Signalling
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Developments in the Medicinal Chemistry of NK2 Receptor Antagonists
Current Topics in Medicinal Chemistry The Therapeutic Index of Locally Acting Inhaled Drugs as a Function of their Fine Particle Mass and Particle Size Distribution – A Literature Review
Current Drug Delivery